Drug intelligence / Profile preview

Xinju nebulized liquid

Development stage: Preclinical
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Inhalation

Overview

**Xinju nebulized liquid** is an investigational traditional Chinese medicine preparation administered as a nebulized liquid for allergic rhinitis. A prospective randomized controlled study registered in China evaluated its efficacy and safety in allergic rhinitis; the public registry identifies Guangdong Provincial Hospital of Chinese Medicine as the sponsor. Its specific herbal composition, molecular targets, and pharmacologic mechanism have not been publicly detailed in the available registry record. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=124049))

Other names: Xinju辛菊雾化液

Beyond the preview

Go deeper on Xinju nebulized liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinju nebulized liquid.

Explore the full profile